Understanding 4H Leukodystrophy (POLR3-Related)
At a Glance
4H leukodystrophy, also called POLR3-related leukodystrophy, is a rare genetic disorder that affects myelin, the brain’s nerve insulation, and may affect teeth and puberty. Symptoms and progression vary widely, so care focuses on each person’s motor, speech, hormone-related, and daily-living needs.
Receiving a diagnosis of 4H leukodystrophy (also known as POLR3-related leukodystrophy) can feel overwhelming. It is a rare, complex genetic condition that affects the development of the nervous system, teeth, and certain hormones [1]. Because it is so rare, you may have found very little information, or what you have found might seem technical and frightening. It is important to remember that while the name describes a specific set of symptoms, every person’s journey with this condition is unique [2][3].
What the “4H” Name Means
The name “4H” is a shorthand that doctors use to describe four clinical terms often used in the classic presentation. However, not every person will have all four “H” features, and they can appear at different times [2][4].
- Hypomyelination: This is the core feature. Myelin is the protective, fatty coating that acts like insulation around the “wires” (nerve fibers) in the brain. In 4H, the brain does not produce enough of this insulation from the start [1][5].
- Hypodontia: This refers to missing teeth or teeth that develop abnormally. Some people may have fewer than the normal number of permanent teeth, or their teeth may erupt in a different order or later than expected [1][6].
- Hypogonadotropic: This is a medical term referring to a lack of the signaling hormones sent from the brain to the reproductive system [1][2].
- Hypogonadism: This refers to the resulting delay or absence of puberty and sexual development that happens because the brain has trouble sending those right hormonal signals to the body [6][4].
The Role of RNA Polymerase III (Pol III)
To understand what causes 4H, it helps to think of the body as a vast construction site. Inside every cell, there is a specialized “machine” called RNA polymerase III (or Pol III). This machine’s job is to read the blueprints (DNA) and build small, essential tools called tRNAs [6][7]. These tools are necessary for the cell to build proteins, which are the building blocks of everything in the body—including myelin [8].
In people with 4H, there are “typos” (pathogenic variants) in the genes that provide instructions for building the Pol III machine—most commonly the POLR3A, POLR3B, POLR1C, or POLR3K genes [1][9]. Because the machine is slightly altered, the brain’s “insulation crews” (oligodendrocytes) may not be able to do their job effectively [8][10]. This leads to the characteristic lack of myelin seen on an MRI, though the exact reasons why these specific variants affect myelin, teeth, and endocrine tissues so selectively remain incompletely understood.
How Common is 4H Leukodystrophy?
4H leukodystrophy is considered an ultra-rare disease. Because it is so rare, and because it was only relatively recently identified as a specific genetic disorder (around 2011), we do not have an exact number for how many people are affected worldwide [11][12]. While researchers are seeing it diagnosed more often now that genetic testing is more accessible, it remains a condition that many doctors may only see once or twice in their entire careers [11].
Understanding the Disease Course
The course of 4H leukodystrophy is highly variable, meaning it looks different from one person to the next, even among siblings with the same genetic variants [13].
- Early Childhood Onset: Most commonly, symptoms appear in early childhood. This often begins with mild delays in walking or “clumsiness” (ataxia) [14].
- Progressive Nature: Over time, there is typically a slow progression of neurological symptoms. This can include increased stiffness in the legs (spasticity), tremors, and gradual changes in speech or swallowing [14][15]. While global developmental delay or learning problems can occur, POLR3-related disease is often motor-predominant, and cognitive function can be variable and sometimes relatively preserved.
- Variable Severity: Some people may have a very stable course for many years, while others may experience more rapid changes. In rare, severe cases, symptoms can appear in infancy and progress more quickly [16]. Conversely, some individuals are not diagnosed until adolescence or even adulthood, presenting with milder walking difficulties or primary amenorrhea [3][17].
Living with Uncertainty
It is completely normal to feel a range of emotions—grief, anger, confusion, and fear—after a 4H diagnosis. Because the condition is so variable, doctors often cannot give you a precise “crystal ball” view of exactly what the future holds. This uncertainty is one of the hardest parts of the journey [2]. Focusing on supporting current needs through physical, occupational, and speech therapy can help maximize abilities and quality of life at every stage [18]. Finding a community of other families facing leukodystrophy can also provide vital emotional support and shared wisdom.
Common questions in this guide
What does the name 4H leukodystrophy mean?
Which genes are linked to POLR3-related leukodystrophy?
What symptoms can 4H leukodystrophy cause, and when do they start?
How can 4H leukodystrophy affect teeth and puberty?
How is 4H leukodystrophy diagnosed?
What support or treatment is available for someone with 4H leukodystrophy?
Can doctors predict the future course of 4H leukodystrophy?
Get notified when new evidence is published on 4H leukodystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (18)
- 1
Inherited white matter disorders: Hypomyelination (myelin disorders).
Perrier S, Gauquelin L, Bernard G
Handbook of clinical neurology 2024; (204()):197-223 doi:10.1016/B978-0-323-99209-1.00014-4.
PMID: 39322379 - 2
Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C.
Pelletier F, Perrier S, Cayami FK, et al.
The Journal of clinical endocrinology and metabolism 2021; (106(2)):e660-e674 doi:10.1210/clinem/dgaa700.
PMID: 33005949 - 3
A novel POLR3A genotype leads to leukodystrophy type-7 in two siblings with unusually late age of onset.
Campopiano R, Ferese R, Zampatti S, et al.
BMC neurology 2020; (20(1)):258 doi:10.1186/s12883-020-01835-9.
PMID: 32600288 - 4
Endocrine Care of a 19-year-old Woman With Isolated Hypogonadotropic Hypogonadism due to 4H Syndrome.
Nwatamole B, Kundu S, Odukudu GO, et al.
AACE clinical case reports 2024; (10(6)):229-231 doi:10.1016/j.aace.2024.08.001.
PMID: 39734507 - 5
4H Leukodystrophy: Lessons from 3T Imaging.
Cayami FK, Bugiani M, Pouwels PJW, et al.
Neuropediatrics 2018; (49(2)):112-117 doi:10.1055/s-0037-1608780.
PMID: 29179231 - 6
POLR3-related leukodystrophy: How do mutations affecting RNA polymerase III subunits cause hypomyelination?
Coulombe B, Derksen A, La Piana R, et al.
Faculty reviews 2021; (10()):12 doi:10.12703/r/10-12.
PMID: 33659930 - 7
Molecular basis of neurodegeneration in a mouse model of Polr3-related disease.
Moir RD, Merheb E, Chitu V, et al.
eLife 2024; (13()).
PMID: 39499645 - 8
Decreased RNA polymerase III subunit expression leads to defects in oligodendrocyte development.
Macintosh J, Michell-Robinson M, Chen X, Bernard G
Frontiers in neuroscience 2023; (17()):1167047 doi:10.3389/fnins.2023.1167047.
PMID: 37179550 - 9
Novel Pathogenic Variants in POLR3K Cause POLR3-Related Leukodystrophy.
Perrier S, Macintosh J, Misiaszek AD, et al.
Human mutation 2024; (2024()):8807171 doi:10.1155/2024/8807171.
PMID: 40225923 - 10
Defective myelination in an RNA polymerase III mutant leukodystrophic mouse.
Merheb E, Cui MH, DuBois JC, et al.
Proceedings of the National Academy of Sciences of the United States of America 2021; (118(40)) doi:10.1073/pnas.2024378118.
PMID: 34583988 - 11
Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing.
Schmidt JL, Pizzino A, Nicholl J, et al.
American journal of medical genetics. Part A 2020; (182(8)):1906-1912 doi:10.1002/ajmg.a.61641.
PMID: 32573057 - 12
Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients.
Ji H, Li D, Wu Y, et al.
PloS one 2018; (13(2)):e0188869 doi:10.1371/journal.pone.0188869.
PMID: 29451896 - 13
Case report: Biallelic variants in POLR3B gene lead to 4H leukodystrophy from the study of brother and sister.
Bai H, Li D, Zheng Y, Jiang X
Medicine 2022; (101(34)):e30350 doi:10.1097/MD.0000000000030350.
PMID: 36042647 - 14
POLR3-related leukodystrophy caused by biallelic POLR3A and 1C pathogenic variants: a single-center experience.
Liu J, Niu Y, Qin J, Yang Z
Frontiers in neurology 2024; (15()):1355484 doi:10.3389/fneur.2024.1355484.
PMID: 38550343 - 15
Novel mutations of the POLR3A gene caused POLR3-related leukodystrophy in a Chinese family: a case report.
Wu S, Bai Z, Dong X, et al.
BMC pediatrics 2019; (19(1)):289 doi:10.1186/s12887-019-1656-7.
PMID: 31438894 - 16
Expanding the phenotypic and molecular spectrum of RNA polymerase III-related leukodystrophy.
Perrier S, Gauquelin L, Fallet-Bianco C, et al.
Neurology. Genetics 2020; (6(3)):e425 doi:10.1212/NXG.0000000000000425.
PMID: 32582862 - 17
Case Report: Severe Osteoporosis and Preventive Therapy in RNA Polymerase III-Related Leukodystrophy.
Furukawa S, Kunii M, Doi H, et al.
Frontiers in neurology 2021; (12()):622355 doi:10.3389/fneur.2021.622355.
PMID: 33716926 - 18
A novel homozygous mutation in POLR3A gene causing 4H syndrome: a case report.
Tewari VV, Mehta R, Sreedhar CM, et al.
BMC pediatrics 2018; (18(1)):126 doi:10.1186/s12887-018-1108-9.
PMID: 29618326
This page is for informational purposes only and does not constitute medical advice about 4H leukodystrophy. A neurologist, medical geneticist, and other members of your care team can interpret your genetic, MRI, endocrine, and developmental findings.